Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platform:
Non-Regulatory
2023-03-18
Non-Regulatory
2023-03-07
report
20 Apr
Annual Report 2022
event
23 May
AGM Annual General Meeting 2023
There are currently no posts in the reports and events archive.
Affibody has a broad pipeline with the most advanced projects in clinical studies. The pipeline is designed to demonstrate the value and versatility of the Affibody® technology.
It is the competence and the engagement of all coworkers that make Affibody an inspiring and exciting place to work at. We know we reach much further in innovation, efficiency and quality by having a work place where we as coworkers care for each other, are ambitious and know and value our own contribution to the end result.
